[Clinical experience with methoxybutropate vs. bromelin in the treatment of female pelvic inflammation].
This study reports the results of a controlled randomized clinical trial performed on 30 young women with PID (Pelvic Inflammatory Disease), using a new anti- inflammatory-analgesic: methoxybutropate. The quali-quantitative symptomatical assessment showed that the improvement of the pain has been more marked and faster with methoxybutropate than hot observed in control group treated with bromeline.